By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Pacira Pharmaceuticals, Inc. 

10450 Science Center Drive

San Diego  California  92121  U.S.A.
Phone: 858-625-2414 Fax: 858-678-3999



Company News
Pacira (PCRX) Announces Completion Of End-of-Review Process With FDA Regarding EXPAREL sNDA For Nerve Block 5/28/2015 10:39:39 AM
Pacira (PCRX) To Present At Investor Conferences In June 5/21/2015 12:07:40 PM
Pacira (PCRX) Announces New Data Supporting Clinical And Pharmacoeconomic Utility Of EXPAREL In Patients Undergoing Various Surgical Procedures 5/20/2015 1:24:50 PM
Pacira (PCRX) Reports First Quarter EXPAREL Revenues Of $56.0 Million And First Quarter 2015 Financial Results 4/30/2015 12:29:35 PM
Pacira (PCRX) Receives Subpoena From The U.S. Department Of Justice 4/16/2015 1:36:31 PM
Pacira (PCRX) Announces Timing For First Quarter 2015 Financial Results Webcast And Conference Call 4/13/2015 8:23:07 AM
Pacira (PCRX) Announces New Data On Health Economic Benefits Of EXPAREL For Postsurgical Pain Control Following Total Knee Replacement Surgery 4/10/2015 12:44:34 PM
Pacira (PCRX) Announces Data Reinforcing Benefits Of EXPAREL For Postsurgical Pain Control Following Total Hip And Knee Replacement Surgery 3/26/2015 8:45:11 AM
Pacira (PCRX) Release: New Data Demonstrate Reduced Opioid Requirements Following Use Of EXPAREL In Hysterectomy And Mastectomy Procedures 3/24/2015 2:28:17 PM
Pacira (PCRX) To Present At The Barclays Global Healthcare Conference 3/5/2015 11:07:00 AM